Early responsiveness to continuous erythropoietin receptor activator predicts renal prognosis and is determined by a novel antioxidative marker in non-dialysis chronic kidney disease: a prospective, observational, single-center study
ConclusionResponsiveness to CERA during the first 3 months was an important indicator of CKD progression. Moreover, BAP test results determined responsiveness to CERA. This is the first report to show how antioxidant levels can be a potential marker of CERA’s ability to control anemia in CKD patients.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Anemia | Antidoxidants | Chronic Kidney Disease | Dialysis | Study | Urology & Nephrology